Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder a person can inherit from a parent. It can cause a person to develop dangerously high cholesterol levels. HeFH affects how a ...
Please provide your email address to receive an email when new articles are posted on . Patients with four rare genetic forms of obesity did not have a significant reduction in BMI with setmelanotide.
Homozygous deficiency of alpha 1-atitrypsin is known to predispose to pulmonary emphysema. Measurement of the trypsin inhibitory capacity (TIC) of serum specimens from 28 relatives of a homozygous ...
A randomized phase II trial of medical cannabis to reduce symptom burden in patients with newly diagnosed advanced pancreatic cancer (CanPan). This is an ASCO Meeting Abstract from the 2026 ASCO ...
Genome Wide Association Study (GWAS) of cognitive impairment after blood or marrow transplantation (BMT) for hematologic malignancy. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting ...
Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease
Heterozygous familial hypercholesterolemia (HeFH) is a monogenic disorder that affects about 1 in 500 people, with a higher prevalence in certain subpopulations such as people of Quebecois, Christian ...
In a 24-week, randomized, placebo-controlled trial, evolocumab, a fully human anti-PSCK9 monoclonal antibody, was studied in pediatric patients who had heterozygous familial hypercholesterolemia and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results